Ms. Suzanne M. Foster, M.Ed, MPH, serves as Chief Executive Officer at Adapt health LLC since May 2024 and serves as its Director since 2024 and serves as Chief Executive Officer at Adapt health corp since...

리더십 팀

이름	위치	테뉴어	보상	소유권
Jason Clemens	Chief Financial Officer	4.1yrs	US$2.38m	0.13% $ 1.8m
Albert Prast	Chief Technology Officer	3.7yrs	US$1.80m	0.054% $ 787.6k
Suzanne Foster	Chief Executive Officer & Director	less than a year	데이터 없음	데이터 없음
Scott Barnhart	Chief Operating Officer	no data	데이터 없음	데이터 없음
Christie Archbold	Chief Accounting Officer	1.5yrs	데이터 없음	0.0047% $ 68.0k
Nalin Narayanam	Chief Information Officer	less than a year	데이터 없음	데이터 없음
Wendy Russalesi	Chief Compliance Officer	2.7yrs	데이터 없음	데이터 없음
Jonathan Bush	General Counsel	less than a year	데이터 없음	데이터 없음
Leila Vargas	Executive Vice President of Sales & Marketing	2.3yrs	데이터 없음	데이터 없음
Joel Mills	Chief People Officer	2.7yrs	데이터 없음	데이터 없음
Briah Carey	President of Diabetes	less than a year	데이터 없음	데이터 없음
Christopher Joyce	Secretary	no data	US$2.10m	0% $ 0

1.5yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 관리: AHCO 의 관리팀은 경험 (평균 재직 기간 1.6 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Suzanne Foster	Chief Executive Officer & Director	less than a year	데이터 없음	데이터 없음
Dale Wolf	Independent Chairman of the Board	4.8yrs	US$297.58k	0.073% $ 1.1m
Theodore Lundberg	Independent Director	3.6yrs	US$287.58k	0.64% $ 9.2m
Gregory Belinfanti	Independent Director	3yrs	US$277.58k	0.035% $ 505.4k
Bradley Coppens	Independent Director	4.2yrs	US$306.67k	0.043% $ 623.3k
David Williams	Independent Director	4.2yrs	US$277.58k	0.028% $ 410.7k
Susan Weaver	Independent Director	6.6yrs	US$287.58k	0.056% $ 817.8k
Terence Connors	Independent Director	4.8yrs	US$307.58k	0.042% $ 611.2k
Joshua Parnes	Director	4.8yrs	US$4.05m	0.50% $ 7.3m

4.2yrs

평균 재임 기간

53yo

평균 연령

경험이 풍부한 이사회: AHCO 의 이사회는 경험(평균 재직 기간 4.6 년)으로 간주됩니다.

AdaptHealth 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Insider recently sold US$281k worth of stock

Adapthealth Corp. Announces Scott Barnhart as Chief Operating Officer, Effective September 23, 2024

AdaptHealth Corp. Announces Executive Changes

AdaptHealth Corp. Announces Changes to Board of Directors and Management

AdaptHealth Corp. Announces Richard Barasch Steps Down as Chairman of the Board, Effective June 30, 2024

AdaptHealth Corp., Annual General Meeting, Jun 20, 2024

Recent updates

Insider recently sold US$281k worth of stock

AdaptHealth Corp.'s (NASDAQ:AHCO) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Adapthealth Corp. Announces Scott Barnhart as Chief Operating Officer, Effective September 23, 2024

AdaptHealth Corp. Announces Executive Changes

Second quarter 2024 earnings: EPS misses analyst expectations

AdaptHealth Corp. Updates Financial Guidance for the Fiscal Year 2024

AdaptHealth Corp. to Report Q2, 2024 Results on Aug 06, 2024

Is There An Opportunity With AdaptHealth Corp.'s (NASDAQ:AHCO) 37% Undervaluation?

AdaptHealth Corp. Announces Changes to Board of Directors and Management

Levi & Korsinsky LLP Encourages to File a Claim Against the Settlement Fund Before Deadline Against Adapthealth Corp

AdaptHealth Corp.'s (NASDAQ:AHCO) Low P/S No Reason For Excitement

Jerry W. Ray V. AdaptHealth Corp. Class Action Reaches Important Milestones

AdaptHealth (NASDAQ:AHCO) Is Reinvesting At Lower Rates Of Return

AdaptHealth Corp. Announces Goodwill Impairment for the First Quarter Ended March 31, 2024

First quarter 2024 earnings released: US$0.016 loss per share (vs US$0.11 profit in 1Q 2023)

AdaptHealth Corp. to Report Q1, 2024 Results on May 07, 2024

AdaptHealth Corp. Announces Richard Barasch Steps Down as Chairman of the Board, Effective June 30, 2024

AdaptHealth Corp., Annual General Meeting, Jun 20, 2024

Here's Why AdaptHealth (NASDAQ:AHCO) Has A Meaningful Debt Burden

Market Might Still Lack Some Conviction On AdaptHealth Corp. (NASDAQ:AHCO) Even After 50% Share Price Boost

Chief Technology Officer notifies of intention to sell stock

Insufficient new directors

AdaptHealth Corp. Provides Earnings Guidance for the Fiscal Year 2024

Price target increased by 13% to US$11.70

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

AdaptHealth Corp. to Report Q4, 2023 Results on Feb 27, 2024

Consensus EPS estimates fall by 34%

Many Still Looking Away From AdaptHealth Corp. (NASDAQ:AHCO)

Price target decreased by 8.7% to US$10.50

Rosen Law Firm Encourages AdaptHealth Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action

AdaptHealth (NASDAQ:AHCO) Use Of Debt Could Be Considered Risky

New minor risk - Share price stability

Adapthealth Corp. Updates Revenue Guidance for the Year 2023

Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against AdaptHealth Corp

AdaptHealth Corp. to Report Q3, 2023 Results on Nov 07, 2023

Returns On Capital At AdaptHealth (NASDAQ:AHCO) Paint A Concerning Picture

Investor sentiment deteriorates as stock falls 16%

Is It Too Late To Consider Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Adapthealth Corp. Announces CEO Changes

Investor sentiment deteriorates as stock falls 17%

Chief Technology Officer notifies of intention to sell stock

AdaptHealth Corp. Provides Revenue Guidance for the Fiscal Year 2023

Price target increased by 8.3% to US$17.03

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Here's What's Concerning About AdaptHealth's (NASDAQ:AHCO) Returns On Capital

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Investor sentiment improves as stock rises 18%

Adapthealth Corp. Announces CEO Changes

Is Now The Time To Look At Buying AdaptHealth Corp. (NASDAQ:AHCO)?

Consensus EPS estimates increase by 13%, revenue downgraded

First quarter 2023 earnings: EPS exceeds analyst expectations

Price target decreased by 19% to US$17.83

AdaptHealth Corp. Announces Stephen Griggs Not to Seek Re-Election to the Board

AdaptHealth's (NASDAQ:AHCO) Returns On Capital Not Reflecting Well On The Business

Here's Why AdaptHealth (NASDAQ:AHCO) Is Weighed Down By Its Debt Load

Consensus EPS estimates fall by 35%

Investor sentiment deteriorates as stock falls 32%

Price target decreased by 17% to US$23.60

Full year 2022 earnings: EPS misses analyst expectations

Why AdaptHealth Corp. (NASDAQ:AHCO) Could Be Worth Watching

Insider recently sold US$941k worth of stock

Investors Interested In AdaptHealth Corp.'s (NASDAQ:AHCO) Earnings

Insider recently sold US$4.0m worth of stock

AdaptHealth Corp. to Report Q4, 2022 Results on Feb 28, 2023

AdaptHealth (NASDAQ:AHCO) Has A Somewhat Strained Balance Sheet

Insider notifies of intention to sell stock

We Ran A Stock Scan For Earnings Growth And AdaptHealth (NASDAQ:AHCO) Passed With Ease

Insider recently sold US$1.7m worth of stock